Cancer Research UK logo.
SearchDonate
  • Search

Treatment for neuroendocrine cancer

Peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumours (NETs)

PRRT is a type of radioisotope therapy for some NETs. It uses a radioactive medicine to target special proteins (receptors) on the NET’s surface. These are called somatostatin receptors.

What is radioisotope therapy?

Radioisotope therapy uses radioactive medicines to treat some cancer types. 

The radioisotope travels around your body in the bloodstream to the area where the cancer is. The radioactive part is called an isotope. It may be attached to another substance, which is designed to take the isotope to the cancer.

The cancer cells take up the radioisotope and get a high dose of radiation, which destroys them. The healthy cells receive a low dose or no radiation. 

Read about radioisotope therapy

There are different types of radioisotope therapy, including PRRT. PRRT is also called:

  • radioligand therapy

  • molecular radiotherapy

  • targeted radiotherapy

  • radio labelled treatment

  • targeted radionuclide therapy

How PRRT works

Some neuroendocrine cells have proteins (​​) on the outside of them. These are called ​​ receptors. The ​​ somatostatin attaches to these receptors and causes changes in the cell. For example, they may tell the cell to slow down the production of hormones. 

Special scans can check whether your NET has these receptors. If your NET has somatostatin receptors, doctors can use these receptors to target radioisotope therapy. 

Find out more about radioactive scans

In the laboratory, doctors attach a radioactive substance to a medicine. The medicine is called a ​​. A somatostatin analogue is a man made (synthetic) version of somatostatin. This radioactive treatment circulates through your body in the bloodstream. It attaches to the somatostatin receptors on the NET cells. The radioactive treatment then enters the cell and kills it from the inside.

Doctors usually use a treatment called lutetium oxodotreotide (Lutathera).

Diagram showing Peptide Receptor Radionuclide Therapy PRRT.

When you might have PRRT

Read more about the difference between NETs and NECs

You have special scans such as ​​ or ​. These can check whether your NET has somatostatin receptors. If it does, your doctors might offer you this treatment for a NET that:

  • started in your ​​  or ​​   

  • has spread or cannot be removed with surgery

  • is grade 1 or grade 2 - this means the NET is slow or moderately fast growing

How you have PRRT

Before

You see a doctor and have blood tests and a physical examination. Your doctor might ask you to stop octreotide or lanreotide injections. If you have these every day, you might stop them for 12 hours before the treatment. If you are have them every month, your doctor might ask you to stop a month before the treatment.  

Your doctor or specialist nurse will tell you which drugs you need to stop before the treatment.

Having PRRT

You usually have treatment in the nuclear medicine department. It can take around 5 hours. 

A doctor puts a small tube (cannula) into your arm or back of your hand. They then attach a drip of ​​ to the cannula. This helps to protect the kidneys from the radioactive treatment.

You have the drip of amino acids for one hour and then you start the radioactive drip. It takes about 30 minutes to have it. 

After the radioactive drip, you continue to have the amino acids infusion for another 3 hours.

You usually have PRRT every 2 to 3 months. You have up to 4 doses of treatment.

After PRRT

After PRRT, you will be slightly radioactive. So you might need to stay in hospital for 1 or 2 days to make sure the radioactivity drops to a safe level before you go home. In some hospitals, you may be able to go home later the same day if you are feeling well.  

You usually have special scans to check how much radiation is left in your body.

After you go home, there are still some safety precautions that you need to follow. Your doctor or specialist nurse will tell you about them and how long you need to do them for. The precautions might include:

  • avoiding close contact, such as hugging with young children and pregnant women

  • double flushing the toilet

  • sleeping in a separate bed to your partner

Side effects of PRRT

PRRT can cause side effects. These include:

A drop in the number of blood cells

You might have a drop in the number of blood cells such as red blood cells, white blood cells and platelets. This can increase your risk of breathlessness, infection and bleeding.

Feeling or being sick

This is usually caused by the amino acids drip. You have anti sickness medicine before the start of treatment to help with this.

Inflammation of the kidneys

This can happen because your body gets rid of the radiation through the kidneys. You have a drip of amino acids before and after the treatment. This is to protect the kidneys from the effect of the radiation.

Pain

Pain can be caused by swelling (oedema) around the NET. Tell your doctor or nurse if you have this, they can give you medicines such as painkillers and steroids to help.

Feeling very tired (fatigue)

You might feel very tired and as though you lack energy.

Follow up after treatment

After you finish treatment, you have regular blood tests. These check how well your kidneys are working and the levels of blood cells in your body.

You usually have blood tests every week or every 2 weeks for the first 2 months. You then have blood tests less often. You may have them at the hospital or at your GP surgery.

Coping with neuroendocrine cancer

Treatment for neuroendocrine cancer can be difficult to cope with for some people. Your nurse will give you phone numbers to call if you have any problems at home. 

Find out more about coping with a neuroendocrine cancer and how to get support

Last reviewed: 07 Feb 2025

Next review due: 07 Feb 2028

What are neuroendocrine cancers?

Neuroendocrine cancers are also called neuroendocrine neoplasms (NENs). There are 2 key groups - neuroendocrine tumours (NETs) and neuroendocrine carcinomas (NECs).

Types of neuroendocrine cancer

There are many different types of neuroendocrine cancer. They are usually named after the part of the body where they develop.

Treatment for neuroendocrine cancer

Treatment depends on the type of neuroendocrine cancer you have, where it is, its size and whether it has spread (the stage).

Radioisotope therapy

Radioisotope therapy uses radioactive medicines to treat some types of cancer. It is also known as radionuclide therapy. You have the radioisotope as a drink, capsule or injection.

Living with neuroendocrine cancer

Practical and emotional support is available to help you cope with neuroendocrine cancer.

Neuroendocrine cancer main page

Neuroendocrine cancers develop in cells of the neuroendocrine system. They can develop in different parts of the body including the lungs, stomach, pancreas and bowel.

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and Support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.